Text Size
54 studies found for:    Open Studies | "Prostatic Hyperplasia"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Prostatic Hyperplasia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown † A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
Condition: Prostatic Hyperplasia
Intervention: Drug: ML-04A
2 Recruiting Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Intervention: Drug: Dutasteride/Tamsulosin
3 Unknown † The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients
Conditions: Prostatic Hyperplasia;   Adrenergic Alpha-Antagonists
Intervention: Drug: Saw palmetto and sanmiaoshan capsule
4 Not yet recruiting Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Device: Embosphere Microspheres;   Procedure: TURP
5 Recruiting Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: combination therapy;   Drug: alpha blocker monotherapy;   Drug: 5 alpha reductase inhibitor monotherapy
6 Unknown † Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions
Condition: Sexual Dysfunctions in Men With Benign Prostatic Hyperplasia
Intervention: Drug: Saw palmetto berry extract
7 Not yet recruiting Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia (BPH)
Intervention: Device: Vortx Rx - Histotripsy BPH Device
8 Recruiting Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: S-equol;   Drug: Placebo
9 Recruiting The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: selective alpha 1-blockers;   Drug: celecoxib;   Drug: alpha-blocker and NSAID
10 Recruiting Clinical Trial of Safety and Efficiency of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Afalaza;   Drug: Placebo
11 Recruiting JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Conditions: Benign Prostatic Hyperplasia;   Chronic Prostatitis
Interventions: Drug: Jalyn;   Drug: Placebo
12 Not yet recruiting Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Finasteride (MK-906);   Drug: Tamsulosin;   Other: Placebo
13 Recruiting Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia (BPH)
Interventions: Device: Greenlight XPS Laser;   Device: BiVAP Saline Vaporization of the prostate
14 Recruiting A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy
Condition: Prostatic Hyperplasia
Interventions: Drug: BONT-A intra-prostatic injection;   Drug: Optimized medical BPH treatment
15 Recruiting Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With Benign Prostatic Hyperplasia and Lower Urinary Track Symptoms (BPH)
Conditions: Benign Prostatic Hyperplasia;   Lower Urinary Track Symptoms
Interventions: Drug: onaBoNT-A + placebo;   Drug: Tamsulosin + placebo
16 Recruiting Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
Conditions: Benign Prostatic Hyperplasia;   BPH;   Lower Urinary Tract Symptoms (LUTS);   LUTS;   Enlarged Prostate
Intervention: Drug: NX-1207
17 Recruiting Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Conditions: Overactive Bladder;   Benign Prostatic Hyperplasia
Intervention: Drug: doxazosin plus tolterodine SR
18 Recruiting Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms
Conditions: Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia
Interventions: Drug: MCS-2;   Drug: Placebo
19 Recruiting Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)
Conditions: Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia
Intervention: Drug: MCS-2
20 Recruiting Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms
Conditions: Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia
Intervention: Drug: MCS-2
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years